CVR number 74422411
Industry 26.6090 Manufacture of irradiation, electromedical and electrotherapeutic equipment

MAGNATEK ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.3% 2.3% 2.3% 2.3% 2.3%  
Bankruptcy risk  0.8% 0.5% 1.5% 0.8% 0.7%  
Credit score (0-100)  91 99 75 93 92  
Credit rating  A AAA A AA AA  
Credit limit (kDKK)  836.7 1,338.2 14.5 671.9 761.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  7,508 11,306 7,937 12,417 15,141  
EBITDA  2,179 4,401 1,378 3,995 4,403  
EBIT  2,028 4,268 514 3,768 4,181  
Pre-tax profit (PTP)  1,932.3 4,160.9 320.9 3,544.9 3,952.0  
Net earnings  1,506.3 3,245.2 248.8 2,770.5 3,081.8  
Pre-tax profit without non-rec. items  1,932 4,161 321 3,545 3,952  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  315 182 1,666 1,619 1,396  
Shareholders equity total  6,458 6,203 1,452 3,222 3,304  
Interest-bearing liabilities  0.2 2,241 9,964 9,347 7,453  
Balance sheet total (assets)  9,724 13,803 14,265 16,871 15,261  
Net Debt  -3,558 -4,116 9,671 8,655 6,644  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  7,508 11,306 7,937 12,417 15,141  
Gross profit growth  -25.3% 50.6% -29.8% 56.4% 21.9%  
Employees  11 11 11 14 16  
Employee growth %  37.5% 0.0% 0.0% 27.3% 14.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  9,724 13,803 14,265 16,871 15,261  
Balance sheet change%  -23.7% 41.9% 3.3% 18.3% -9.5%  
Added value  2,178.8 4,400.6 1,377.8 4,631.4 4,403.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -185 -266 620 -274 -444  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  27.0% 37.7% 6.5% 30.3% 27.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  18.1% 36.3% 4.7% 25.7% 28.0%  
ROI %  23.2% 51.2% 6.0% 30.7% 34.8%  
ROE %  26.4% 51.3% 6.5% 118.5% 94.4%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  64.8% 44.9% 10.2% 19.1% 21.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -163.3% -93.5% 701.9% 216.6% 150.9%  
Gearing %  0.0% 36.1% 686.3% 290.1% 225.5%  
Net interest  0 0 0 0 0  
Financing costs %  4.8% 9.5% 5.5% 4.8% 6.5%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.8 1.4 0.7 0.8 0.7  
Current Ratio  3.9 2.0 1.1 1.2 1.3  
Cash and cash equivalent  3,558.2 6,356.9 292.3 691.7 808.9  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  6,930.4 6,827.5 623.3 2,798.1 3,213.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  198 400 125 331 275  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  198 400 125 285 275  
EBIT / employee  184 388 47 269 261  
Net earnings / employee  137 295 23 198 193